Data falsification: still a problem in drug plants in India and China - STAT

Data falsification: still a problem in drug plants in India and China - STAT

What to read around the web today

• Opinion: In generic drug plants in China and India, data falsification is still a problem. STAT
• Missouri Health Director tracked menstrual periods of Planned Parenthood patients. NBC News
• Taking stock of Alzheimer’s research: Experts offer takes on Biogen, the NIH, and the amyloid hypothesis. STAT Plus
• Juul shipped at least a million contaminated pods, new lawsuit says. BuzzFeed News
• Johnson & Johnson says recalled baby powder doesn’t have asbestos. The New York Times